Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 4;7(6):e24235.
doi: 10.2196/24235.

Factors Influencing Clinicians' Willingness to Prescribe Pre-exposure Prophylaxis for Persons at High Risk of HIV in China: Cross-sectional Online Survey Study

Sitong Cui #  1   2   3   4 , Haibo Ding #  1   2   3   4 , Xiaojie Huang  5 , Hui Wang  6 , Weiming Tang  7 , Sequoia I Leuba  8 , Zehao Ye  1   2   3   4 , Yongjun Jiang  1   2   3   4 , Wenqing Geng  1   2   3   4 , Junjie Xu  1   2   3   4 , Hong Shang  1   2   3   4
Affiliations

Factors Influencing Clinicians' Willingness to Prescribe Pre-exposure Prophylaxis for Persons at High Risk of HIV in China: Cross-sectional Online Survey Study

Sitong Cui et al. JMIR Public Health Surveill. .

Abstract

Background: Pre-exposure prophylaxis (PrEP) is an effective HIV prevention measure. Clinicians play a crucial role in PrEP implementation, and their knowledge, attitudes, and career experience may affect their willingness to prescribe PrEP. However, little is known about the attitudes and willingness of clinicians to prescribe PrEP in countries without PrEP-specific guidelines.

Objective: We aimed to determine the factors associated with clinicians being willing to prescribe PrEP in China.

Methods: Between May and June 2019, we conducted an online cross-sectional survey of clinicians in 31 provinces across the six administrative regions in China on the WeChat smartphone app platform. Multivariable logistic regression was used to determine factors associated with willingness to prescribe PrEP.

Results: Overall, 777 HIV clinicians completed the survey. Most of the respondents had heard of PrEP (563/777, 72.5%), 31.9% (248/777) thought that PrEP was extremely effective for reducing the risk of HIV infection, and 47.2% (367/777) thought that it was necessary to provide PrEP to high-risk groups. After adjusting for age, gender, ethnicity, and educational background of the clinicians, the following factors significantly increased the odds of the clinicians being willing to prescribe PrEP: having worked for more than 10 years, compared to 5 years or less (adjusted odds ratio [aOR] 2.82, 95% CI 1.96-4.05); having treated more than 100 patients living with HIV per month, compared to 50 patients or fewer (aOR 4.16, 95% CI 2.85-6.08); and having heard of PrEP (aOR 7.32, 95% CI 4.88-10.97). Clinicians were less likely to be willing to prescribe PrEP if they were concerned about poor adherence to PrEP (aOR 0.66, 95% CI 0.50-0.88), the lack of PrEP clinical guidelines (aOR 0.47, 95% CI 0.32-0.70), and the lack of drug indications for PrEP (aOR 0.49, 95% CI 0.32-0.76).

Conclusions: About half of all clinicians surveyed were willing to prescribe PrEP, but most surveyed had a low understanding of PrEP. Lack of PrEP clinical guidelines, lack of drug indications, and less than 11 years of work experience were the main barriers to the surveyed clinicians' willingness to prescribe PrEP. Development of PrEP clinical guidelines and drug indications, as well as increasing the availability of PrEP training, could help improve understanding of PrEP among clinicians and, thus, increase the number willing to prescribe PrEP.

Keywords: China; HIV prevention; WeChat; clinicians; pre-exposure prophylaxis; willingness to prescribe.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
The six administrative regions of China.
Figure 2
Figure 2
Predictors of clinicians being willing to prescribe pre-exposure prophylaxis (PrEP) (N=777). aOR: adjusted odds ratio; Ref.: reference; STD: sexually transmitted disease.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Koss CA, Charlebois ED, Ayieko J, Kwarisiima D, Kabami J, Balzer LB, Atukunda M, Mwangwa F, Peng J, Mwinike Y, Owaraganise A, Chamie G, Jain V, Sang N, Olilo W, Brown LB, Marquez C, Zhang K, Ruel TD, Camlin CS, Rooney JF, Black D, Clark TD, Gandhi M, Cohen CR, Bukusi EA, Petersen ML, Kamya MR, Havlir DV, SEARCH Collaboration Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020 Apr;7(4):e249–e261. doi: 10.1016/S2352-3018(19)30433-3. https://linkinghub.elsevier.com/retrieve/pii/S2352-3018(19)30433-3 - DOI - PMC - PubMed
    1. Peng L, Cao W, Gu J, Hao C, Li J, Wei D, Li J. Willingness to use and adhere to HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in China. Int J Environ Res Public Health. 2019 Jul 23;16(14):2620. doi: 10.3390/ijerph16142620. https://www.mdpi.com/resolver?pii=ijerph16142620 - DOI - PMC - PubMed
    1. UNAIDS Data 2019. Geneva, Switzerland: UNAIDS; 2019. [2021-05-22]. https://www.unaids.org/en/resources/documents/2019/2019-UNAIDS-data.
    1. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva, Switzerland: World Health Organization; 2015. Sep, [2021-05-30]. https://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/ - PubMed
    1. Miles to Go: Closing Gaps, Breaking Barriers, Righting Injustices. Geneva, Switzerland: UNAIDS; 2018. [2021-05-22]. https://www.unaids.org/en/resources/documents/2018/global-aids-update.

Publication types

Substances